Search results for "BREAST"

showing 10 items of 1871 documents

Relation of elastosis to biochemical and immunohistochemical steroid receptor findings, Ki-67 and epidermal growth factor receptor (EGFR) immunostain…

1993

We studied 1073 cases of invasive ductal breast cancer, NOS for their elastic content (DEL, ductal+periductal elastosis; TEL, tumour elastosis) and compared the findings with the results of biochemical and immunohistochemical steroid hormone receptor examination. Tumours of patients up to 50 years of age and older were examined separately. In a number of tumours elastosis was also examined in relation to Ki-67 and epidermal growth factor receptor (EGFR) immunostaining. Sensitivity and specificity of DEL and TEL for predicting the receptor, Ki-67 and EGFR findings were estimated. Sensitivity of DEL and TEL for oestrogen and progesterone receptors is dependent on the degree of tumour differen…

Pathologymedicine.medical_specialtySteroid hormone receptorMammary glandBreast NeoplasmsBiologySensitivity and SpecificityPathology and Forensic MedicineBreast cancerEpidermal growth factormedicineHumansEpidermal growth factor receptorConnective Tissue DiseasesMolecular BiologyEpitheliomaNuclear ProteinsCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseNeoplasm ProteinsErbB ReceptorsReceptors Antigenmedicine.anatomical_structureCarcinoma Intraductal NoninfiltratingKi-67 AntigenKi-67biology.proteinImmunohistochemistryFemaleVirchows Archiv. A, Pathological anatomy and histopathology
researchProduct

Comparative morphometric evaluation of microvessel density and nuclear area in ductal carcinoma in situ and hyperplastic ductal breast lesions

1999

Abstract Tumour angiogenesis, as assayed by microvessel density, has been proposed as a prognostic factor in invasive breast cancer. Angiogenesis in noninvasive tumours and hyperplastic mammary lesion has not been well-established. The aim of the present study was to evaluate the microvessel density in ductal proliferative breast lesions and to investigate the relationships between microvessel density and histopathologic features. In addition, morphometric measurement of nuclear area in ductal proliferative breast lesions and its relationship with microvessel density has been examined. Thirty-four cases were evaluated, 19 ductal carcinomas in situ (DCIS) and 15 of usual and atypical ductal …

Pathologymedicine.medical_specialtyStromal cellbusiness.industryAngiogenesisGeneral MedicineDuctal carcinomamedicine.diseaseLesionBreast cancermedicine.anatomical_structureMedicineSurgeryFeulgen stainmedicine.symptomskin and connective tissue diseasesbusinessMicrovesselBlood vesselThe Breast
researchProduct

PHC-025 Single Nucleotide Polymorphisms Associated with Adverse Events in Taxane-Treated Breast Cancer Patients

2013

Background Inter-individual differences in drug efficacy and toxicity are linked, in many cases, to single nucleotide polymorphisms (SNPs) in genes coding for drug metabolising enzymes and transporters. Taxanes are active for several tumour types, including breast cancer. But this is limited by adverse events such as neurotoxicity and haematological toxicity. Purpose To evaluate the associations between a panel of 92 SNPs in 33 genes and adverse events developed by breast cancer patients treated with taxanes. Materials and Methods Between June 2011 and May 2012 breast cancer patients treated with taxanes who gave informed consent were genotyped for 92 SNPs in 33 genes. Genomic DNA was analy…

Pathologymedicine.medical_specialtyTaxanebusiness.industrySingle-nucleotide polymorphismNeutropeniamedicine.diseaseGastroenterologyExact testBreast cancerDocetaxelInternal medicineGenotypemedicineGeneral Pharmacology Toxicology and PharmaceuticsAdverse effectbusinessmedicine.drugEuropean Journal of Hospital Pharmacy
researchProduct

A xanthogranulomatous process resembling residual disease on endof- treatment 18f-FDG-PET/CT and Whole Body Magnetic Resonance performed on a primary…

2016

We report the case of a woman, affected by breast diffuse large B-Cell lymphoma, who developed a xanthogranulomatous process wrongly interpreted as residual disease on 18F-FDG-PET/CTand Whole Body Magnetic Resonance after treatment with ibrutinib plus standard immunochemotherapy. Newer drugs, such as immunomodulatory agents and checkpoint inhibitors, have demonstrated high effectiveness on lymphoma, but are associated with unclear imaging features such as tumor flare or pseudo-progression, related to inflammatory reactions. Wide imaging techniques availability improves diagnostic possibilities. However, the awareness of the adopted treatment strategy and its possible implications on imaging…

Pathologymedicine.medical_specialtyWhole body magnetic rcsonanccmedicine.diagnostic_testbusiness.industryIbrutinibObstetrics and GynecologyMagnetic resonance imagingCHOPFDG-PET/CTBrcasr lymphoma; FDG-PET/CT; Ibrutinib; Rituximab; Whole body magnetic rcsonancc; Xantogranulomatous process; Obstetrics and GynecologyPrimary Breast Lymphomachemistry.chemical_compoundchemistryXantogranulomatous proceIbrutinibmedicineFdg pet ctRituximabRituximabWhole bodybusinessNuclear medicineBrcasr lymphomamedicine.drugGiornale Italiano di ostetricia e ginecologia
researchProduct

Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells

2010

Aim:  The unexpected identification of myoglobin (MB) in breast cancer prompted us to evaluate the clinico-pathological value of MB, haemoglobin (HB) and cytoglobin (CYGB) in human breast carcinoma cases. We further screened for the presence of neuroglobin (NGB) and CYGB in tumours of diverse origin, and assessed the O2-response of HB, MB and CYGB mRNAs in cancer cell lines, to better elicit the links between this ectopic globin expression and tumour hypoxia. Methods:  Breast tumours were analysed by immunohistochemistry for HB, MB and CYGB and correlated with clinico-pathological parameters. Screening for CYGB and NGB mRNA expression in tumour entities was performed by hybridization, quant…

Pathologymedicine.medical_specialtybiologyPhysiologyCytoglobinmedicine.diseasebiology.organism_classificationHeLaBreast cancerReal-time polymerase chain reactionNeuroglobinCancer cellmedicineCancer researchImmunohistochemistryGlobinActa Physiologica
researchProduct

Concomitant Small Cell Neuroendocrine Carcinoma of Gallbladder and Breast Cancer

2014

The neuroendocrine carcinoma is defined as a high-grade malignant neuroendocrine neoplasm arising from enterochromaffin cells, usually disposed in the mucosa of gastric and respiratory tracts. The localization in the gallbladder is rare. Knowledge of these gallbladder tumors is limited and based on isolated case reports. We describe a case of an incidental finding of small cell neuroendocrine carcinoma of the gallbladder, observed after cholecystectomy for cholelithiasis, in a 55-year-old female, who already underwent quadrantectomy and sentinel lymph-node biopsy for breast cancer. The patient underwent radiotherapy for breast cancer and six cycles of chemotherapy with cisplatin and etoposi…

Pathologymedicine.medical_specialtybusiness.industryGallbladdermedicine.medical_treatmentlcsh:SurgeryCase Reportlcsh:RD1-811Settore MED/08 - Anatomia PatologicaMalignancymedicine.diseaseRadiation therapySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureBreast cancerNeuroendocrine carcinomamedicineEnterochromaffin cellPharmacology (medical)CholecystectomyNeoplastic transformationbusinessQuadrantectomy
researchProduct

<title>Multiparameter breast cancer cell image analysis for objective estimation of nuclear grade: comparison with light microscopic observatio…

2000

We performed a multi parameter image analysis assessment of breast cancer cell population nuclear grade (NG), which is regarded as one of the main prognostic factors for treatment efficacy and survival of the patients and compared it with light microscopic estimation of NG. Cytological imprint slides from 20 ductal carcinomas were stained according to Leischmann-AzureII-eosine method, and NG was estimated by light microscopic observation according to Black in Fisher's modification. Simultaneously, using specially elaborated software, in each patient 100 cancer cells were analyzed for nuclear perimeter, diameter, area, nucleolar area, and average intensity of staining. The chromatin structur…

Pathologymedicine.medical_specialtyeducation.field_of_studymedicine.diagnostic_testbusiness.industryPopulationMammary glandCancermedicine.diseaseCell nucleusBreast cancerFine-needle aspirationmedicine.anatomical_structureCancer cellMedicinebusinessNuclear medicineeducationSurvival analysisSPIE Proceedings
researchProduct

Quantitative Evaluation of HER-2/neuStatus in Breast Cancer by Fluorescence In Situ Hybridization and by Immunohistochemistry With Image Analysis

2001

We correlated quantitative results obtained in 40 invasive breast cancer cases for HER-2 gene amplification by fluorescence in situ hybridization with protein expression by immunohistochemical studies with computer-assisted image analysis. Fluorescence in situ hybridization (FISH) results were quantified as the mean number of fluorescent signals per nucleus, and immunohistochemical slides were read by semiquantitatively assessing membranous immunostaining intensity in tumor cells vs nonneoplastic breast tissue or quantitatively evaluated by image analysis. We found high correlation between immunohistochemical results by semiquantitative scoring and by image analysis. FISH results correlated…

Pathologymedicine.medical_specialtymedicine.diagnostic_testMammary glandGeneral MedicineIn situ hybridizationBiologymedicine.diseaseStainingBreast cancermedicine.anatomical_structuremedicineCarcinomaImmunohistochemistryImmunostainingFluorescence in situ hybridizationAmerican Journal of Clinical Pathology
researchProduct

89 Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89 Zr Radiochemistry

2017

Contains fulltext : 181624.pdf (Publisher’s version ) (Open Access) Immuno-positron emission tomography (immunoPET) with (89)Zr-labeled antibodies has shown great potential in cancer imaging. It can provide important information about the pharmacokinetics and tumor-targeting properties of monoclonal antibodies and may help in anticipating on toxicity. Furthermore, it allows accurate dose planning for individualized radioimmunotherapy and may aid in patient selection and early-response monitoring for targeted therapies. The most commonly used chelator for (89)Zr is desferrioxamine (DFO). Preclinical studies have shown that DFO is not an ideal chelator because the (89)Zr-DFO complex is partly…

Pathologymedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentmonoclonal-antibodiesBiomedical Engineeringrational designPharmaceutical Sciencebifunctional chelating-agentBioengineeringCancer imagingReviewgrowth-factorRare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9]010402 general chemistryMonoclonal antibody01 natural sciencesDose planningp-isothiocyanatobenzyl-desferrioxamineIn vivo[ CHIM.ORGA ] Chemical Sciences/Organic chemistryimmuno-petmedicineIn patient[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biology[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyPharmacologymedicine.diagnostic_test010405 organic chemistrybusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryOrganic Chemistrydrug development3. Good health0104 chemical sciencesDrug developmentPositron emission tomographyRadioimmunotherapyUrological cancers Radboud Institute for Health Sciences [Radboudumc 15]click chemistryCancer researchmetastatic breast-cancerbusinessbearing nude-miceNanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19]BiotechnologyBioconjugate Chemistry
researchProduct

Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investiga…

2014

Antonio Ieni,1 Valeria Barresi,1 Rosario Caltabiano,2 Anna Maria Cascone,3 Rachele Del Sordo,4 Daniela Cabibi,5 Pio Zeppa,3 Salvatore Lanzafame,2 Angelo Sidoni,4 Vito Franco,5 Giovanni Tuccari1 1Department of Human Pathology Gaetano Barresi, Section of Anatomic Pathology, University of Messina, Messina, 2Department GF Ingrassia, Section of Anatomic Pathology, University of Catania, Catania, 3Department of Medicine and Surgery, University of Salerno, Salerno, 4Institute of Pathologic Anatomy and Histology, Division of Cancer Research, University of Perugia, Perugia, 5Department of Human Pathology, Section of Anatomic Pathology, University of Palermo, Palermo, Italy Background: Human epiderma…

Pathologymedicine.medical_specialtysynchronous lymph nodeslcsh:RC254-282OncoTargets and TherapyBreast cancer Human epidermal growth factor receptor 2 Metastases Prognosis Synchronous lymph nodesText miningBreast cancerbreast cancermedicinebreast cancer; human epidermal growth factor receptor 2; metastases; prognosis; synchronous lymph nodesPharmacology (medical)metastasesskin and connective tissue diseasesneoplasmsLymph nodeHuman Epidermal Growth Factor Receptor 2Original Researchbusiness.industryhuman epidermal growth factor receptor 2; breast cancer; synchronous lymph nodes; metastases; prognosishuman epidermal growth factor receptor 2lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasemedicine.anatomical_structureOncologysynchronous lymph nodemetastaseprognosisbusinessBreast carcinoma
researchProduct